AMCP recently hosted its third iteration of the IRA workshop series, bringing together health plans, pharmaceutical manufacturers, PBMs, research institutes, and patient advocacy organizations.

View AMCP letter urging Congress to support 12-month continuous eligibility for adults in Medicaid and the Children’s Health Insurance Program (CHIP) by passing the Stabilize Medicaid and CHIP Coverage Act

Meet Adrian Washington, VP of Client Management at a pharmaceutical company and AMCP member for more than 20 years.

Meet Maher Abdel Sattar, FAMCP, MS, PharmD, a volunteer with AMCP for over 15 years and currently an Associate Director of Affairs Operations at a Pharmaceutical Company.

Meet Macy Meng, an AMCP Student Pharmacist Committee Chair (2024-2025) and AMCP member since 2023.

Learn more about Diplomat Sarah Hulvershorn.

View AMCP comments to the FDA on considerations in demonstrating biosimilar interchangeability with a biologic reference product.

View AMCP comments in response to the 21st Century Cures 2.0 Request for Information.